Literature DB >> 23007841

Agreement between Bayley Scales second and third edition assessments of very low-birth-weight infants.

Rita C Silveira1, Gabriela R Filipouski, Donald J Goldstein, T Michael O'Shea, Renato S Procianoy.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23007841     DOI： 10.1001/archpediatrics.2012.732

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN： 1072-4710


× No keyword cloud information.
  5 in total

1.  The Ages and Stages Questionnaire and Neurodevelopmental Impairment in Two-Year-Old Preterm-Born Children.

Authors:  Jorien M Kerstjens; Ard Nijhuis; Christian V Hulzebos; Deirdre E van Imhoff; Aleid G van Wassenaer-Leemhuis; Ingrid C van Haastert; Enrico Lopriore; Titia Katgert; Renate M Swarte; Richard A van Lingen; Twan L Mulder; Céleste R Laarman; Katerina Steiner; Peter H Dijk
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

2.  Accuracy of the Bayley-II mental development index at 2 years as a predictor of cognitive impairment at school age among children born extremely preterm.

Authors:  Thomas M O'Shea; Robert M Joseph; Elizabeth N Allred; H Gerry Taylor; Alan Leviton; Tim Heeren; Laurie M Douglass; Jean A Frazier; Hernan Jara; Karl C K Kuban
Journal:  J Perinatol       Date:  2018-05-29       Impact factor: 2.521

3.  Comparison of Bayley-2 and Bayley-3 scores at 18 months in term infants following neonatal encephalopathy and therapeutic hypothermia.

Authors:  Sally Jary; Andrew Whitelaw; Lars Walløe; Marianne Thoresen
Journal:  Dev Med Child Neurol       Date:  2013-08-09       Impact factor: 5.449

4.  Comparison of Second and Third Editions of the Bayley Scales in Children With Suspected Developmental Delay.

Authors:  You Gyoung Yi; In Young Sung; Jin Sook Yuk
Journal:  Ann Rehabil Med       Date:  2018-04-30

5.  Which Bayley-III cut-off values should be used in different developmental levels?

Authors:  Pelin Çelik; Iclal Ayranci Sucakli; Halil Ibrahim Yakut
Journal:  Turk J Med Sci       Date:  2020-01-07       Impact factor: 0.973
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.